The potential for an interaction between MRP2 (ABCC2) and various therapeutic agents: probenecid as a candidate inhibitor of the biliary excretion of irinotecan metabolites.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples